CompletedNCT04959188
Needs Assessment for Individuals and Families Affected by Dyskeratosis Congenita (DC) and Related Telomere Biology Disorders (TBD)
Studying Dyskeratosis congenita
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Cancer Institute (NCI)
- Principal Investigator
- Sharon A Savage, M.D.National Cancer Institute (NCI)
- Enrollment
- 53 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2021 – 2023
Study locations (1)
- National Cancer Institute (NCI), Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04959188 on ClinicalTrials.govOther trials for Dyskeratosis congenita
Additional recruiting or active studies for the same condition.